Cited by 1,043Cytokine Signaling Pathways and InteractionsInflammatory Bowel DiseasePsoriasis: Treatment and Pathogenesis

STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing

Open access
Pickert, Geethanjali, Neufert, Clemens, Leppkes, Moritz, Zheng, Yan, Wittkopf, Nadine, Warntjen, Moritz, Lehr, Hans-Anton, Hirth, Sebastian +5 more·2009·Journal of Experimental Medicine

Abstract

Signal transducer and activator of transcription (STAT) 3 is a pleiotropic transcription factor with important functions in cytokine signaling in a variety of tissues. However, the role of STAT3 in the intestinal epithelium is not well understood. We demonstrate that development of colonic inflammation is associated with the induction of STAT3 activity in intestinal epithelial cells (IECs). Studies in genetically engineered mice showed that epithelial STAT3 activation in dextran sodium sulfate colitis is dependent on interleukin (IL)-22 rather than IL-6. IL-22 was secreted by colonic CD11c(+) cells in response to Toll-like receptor stimulation. Conditional knockout mice with an IEC-specific deletion of STAT3 activity were highly susceptible to experimental colitis, indicating that epithelial STAT3 regulates gut homeostasis. STAT3(IEC-KO) mice, upon induction of colitis, showed a striking defect of epithelial restitution. Gene chip analysis indicated that STAT3 regulates the cellular stress response, apoptosis, and pathways associated with wound healing in IECs. Consistently, both IL-22 and epithelial STAT3 were found to be important in wound-healing experiments in vivo. In summary, our data suggest that intestinal epithelial STAT3 activation regulates immune homeostasis in the gut by promoting IL-22-dependent mucosal wound healing.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20082683

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 27

  1. Akira S. 2000 Roles of STAT3 defined by tissue-specific gene targeting. Oncogene. 19: 2607– 2611 10851059
  2. Alonzi T. Newton I.P. Bryce P.J. Di Carlo E. Lattanzio G. Tripodi M. Musiani P. Poli V. 2004 Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitis. Cytokine. 26: 45– 56 15050604
  3. Atreya R. Mudter J. Finotto S. Mullberg J. Jostock T. Wirtz S. Schutz M. Bartsch B. Holtmann M. Becker C. 2000 Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo. Nat. Med. 6: 583– 588 10802717
  4. Becker C. Fantini M.C. Schramm C. Lehr H.A. Wirtz S. Nikolaev A. Burg J. Strand S. Kiesslich R. Huber S. 2004 TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity. 21: 491– 501 15485627
  5. Becker C. Fantini M.C. Wirtz S. Nikolaev A. Kiesslich R. Lehr H.A. Galle P.R. Neurath M.F. 2005 In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy. Gut. 54: 950– 954 15951540 PMC1774595
  6. Bollrath J. Phesse T.J. von Burstin V.A. Putoczki T. Bennecke M. Bateman T. Nebelsiek T. Lundgren-May T. Canli O. Schwitalla S. 2009 gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell. 15: 91– 102 19185844
  7. Brand S. Beigel F. Olszak T. Zitzmann K. Eichhorst S.T. Otte J.M. Diepolder H. Marquardt A. Jagla W. Popp A. 2006 IL-22 is increased in active Crohn’s disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G827– G838 16537974
  8. Cella M. Fuchs A. Vermi W. Facchetti F. Otero K. Lennerz J.K. Doherty J.M. Mills J.C. Colonna M. 2009 A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature. 457: 722– 725 18978771 PMC3772687
  9. Chapman R.S. Lourenco P. Tonner E. Flint D. Selbert S. Takeda K. Akira S. Clarke A.R. Watson C.J. 2000 The role of Stat3 in apoptosis and mammary gland involution. Conditional deletion of Stat3. Adv. Exp. Med. Biol. 480: 129– 138 10959419
  10. Grivennikov S. Karin E. Terzic J. Mucida D. Yu G.Y. Vallabhapurapu S. Scheller J. Rose-John S. Cheroutre H. Eckmann L. Karin M. 2009 IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 15: 103– 113 19185845 PMC2667107
  11. Levy D.E. Darnell J.E. Jr 2002 Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3: 651– 662 12209125
  12. Liu X. Lee Y.S. Yu C.R. Egwuagu C.E. 2008 Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases. J. Immunol. 180: 6070– 6076 18424728 PMC2435016
  13. Lovato P. Brender C. Agnholt J. Kelsen J. Kaltoft K. Svejgaard A. Eriksen K.W. Woetmann A. Odum N. 2003 Constitutive STAT3 activation in intestinal T cells from patients with Crohn’s disease. J. Biol. Chem. 278: 16777– 16781 12615922
  14. Madison B.B. Dunbar L. Qiao X.T. Braunstein K. Braunstein E. Gumucio D.L. 2002 Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine. J. Biol. Chem. 277: 33275– 33283 12065599
  15. Mudter J. Weigmann B. Bartsch B. Kiesslich R. Strand D. Galle P.R. Lehr H.A. Schmidt J. Neurath M.F. 2005 Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases. Am. J. Gastroenterol. 100: 64– 72 15654782
  16. Nenci A. Becker C. Wullaert A. Gareus R. van Loo G. Danese S. Huth M. Nikolaev A. Neufert C. Madison B. 2007 Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature. 446: 557– 561 17361131
  17. Ouyang W. Kolls J.K. Zheng Y. 2008 The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity. 28: 454– 467 18400188 PMC3424508
  18. Pull S.L. Doherty J.M. Mills J.C. Gordon J.I. Stappenbeck T.S. 2005 Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc. Natl. Acad. Sci. USA. 102: 99– 104 15615857 PMC544052
  19. Reinecker H.C. Steffen M. Witthoeft T. Pflueger I. Schreiber S. MacDermott R.P. Raedler A. 1993 Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn’s disease. Clin. Exp. Immunol. 94: 174– 181 8403503 PMC1534387
  20. Rimoldi M. Chieppa M. Salucci V. Avogadri F. Sonzogni A. Sampietro G.M. Nespoli A. Viale G. Allavena P. Rescigno M. 2005 Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat. Immunol. 6: 507– 514 15821737
  21. Strober W. Fuss I. Mannon P. 2007 The fundamental basis of inflammatory bowel disease. J. Clin. Invest. 117: 514– 521 17332878 PMC1804356
  22. Sugimoto K. Ogawa A. Mizoguchi E. Shimomura Y. Andoh A. Bhan A.K. Blumberg R.S. Xavier R.J. Mizoguchi A. 2008 IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118: 534– 544 18172556 PMC2157567
  23. Takeda K. Clausen B.E. Kaisho T. Tsujimura T. Terada N. Forster I. Akira S. 1999 Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity. 10: 39– 49 10023769
  24. Wolk K. Sabat R. 2006 Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev. 17: 367– 380 17030002
  25. Zenewicz L.A. Yancopoulos G.D. Valenzuela D.M. Murphy A.J. Stevens S. Flavell R.A. 2008 Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity. 29: 947– 957 19100701 PMC3269819
  26. Zheng Y. Danilenko D.M. Valdez P. Kasman I. Eastham-Anderson J. Wu J. Ouyang W. 2007 Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. 445: 648– 651 17187052
  27. Zheng Y. Valdez P.A. Danilenko D.M. Hu Y. Sa S.M. Gong Q. Abbas A.R. Modrusan Z. Ghilardi N. de Sauvage F.J. Ouyang W. 2008 Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14: 282– 289 18264109

Cited by

Sorted by citations

Authors
Pickert, G., Neufert, C., Leppkes, M., Zheng, Y., Wittkopf, N., Warntjen, M., Lehr, H.-A., Hirth, S., Weigmann, B., Wirtz, S., Ouyang, W., Neurath, M. F., & Becker, C.
Affiliations
  • Johannes Gutenberg University Mainz (DE)
  • Genentech (US)
  • Centre Hospitalier Universitaire Vaudois (CH)
  • Universitätsklinikum Erlangen (DE)
Corresponding author
Becker, Christoph
Venue
Journal of Experimental Medicine
Published
2009-06-29
Volume
206
Issue
7
Pages
1465-1472
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2169355315
Cited by
1,043
References
3
Citations by year
2026: 59 · 2025: 42 · 2024: 62 · 2023: 68 · 2022: 49 · 2021: 61 · 2020: 62 · 2019: 71 · 2018: 71 · 2017: 63 · 2016: 62 · 2015: 65 · 2014: 72 · 2013: 86 · 2012: 59
FWCI
24.67
Type
journal article
Language
en
Open access
Locations
  • The Journal of Experimental Medicine (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • IRIS (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion, other-oa)
Funders
  • Pfizer
  • Deutsche Forschungsgemeinschaft (SFB548)
  • Genentech
Topics
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords
STAT3, IL-22 signaling, intestinal epithelial cells, mucosal wound healing, colitis, DSS-induced colitis, epithelial restitution, Toll-like receptors, CD11c+ cells, intestinal homeostasis, apoptosis, cellular stress response, conditional knockout mice
MeSH terms
Interleukin-22, Animals, Colitis, Epithelial Cells, Inflammation, Interleukins, Intestinal Mucosa, Mice, Inbred C57BL, Wound Healing, Signal Transduction, Interleukin-6, Dextran Sulfate, Mice, Knockout, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, STAT3 Transcription Factor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review